Yi-Fang Li

2.4k citations
69 papers · 1.4k indexed · 1 hit paper · h-index 24

Yi-Fang Li

62 papers receiving 1.4k citations

Hit Papers

Oxygenated phosphatidylethanolamine navigates phagocytosi...182202120262022202450100150

Peers

Yi-Fang Li
Comparison fields: 5 of 127
  • Biological Psychiatry 64
  • Geriatrics and Gerontology 60
  • Behavioral Neuroscience 50
  • Complementary and alternative medicine 113
  • Pharmacology 116
Replace Yan Guo with:
Yan Guo China
Parveen Kumar India
Xiujing Feng China
Li‐Long Pan China
Eun Kyeong Lee South Korea
Paul W. Hake United States
Lin Luo China
Kandy T. Velázquez United States
Chingju Lin Taiwan
Yi-Fang Li relative to Yan Guo China Yan Guo's profile →
Citations per field
00.5×
Yan Guo · 1×
Citations per year

Countries citing papers authored by Yi-Fang Li

Since Specialization
Citations

This map shows the geographic impact of Yi-Fang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-Fang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-Fang Li more than expected).

Fields of papers citing papers by Yi-Fang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi-Fang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-Fang Li. The network helps show where Yi-Fang Li may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yi-Fang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yi-Fang Li Line = papers co-authored together Yi-Fang Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20246
4 20245
5 20243
6 20240
7 20240
8 202225
9 20223
10 202123
11 202025
12 202023
13 201936
14 201728
15 201657
16 201614
17 201613
18 2015118
19 201429
20 201244

About Yi-Fang Li

Yi-Fang Li is a scholar working on Biological Psychiatry, Behavioral Neuroscience and Complementary and alternative medicine, having authored 69 papers that have together received 1.4k indexed citations. Recurring topics across this work include interferon and immune responses (7 papers), Liver Disease Diagnosis and Treatment (7 papers), Pharmacological Effects of Natural Compounds (6 papers), Herpesvirus Infections and Treatments (5 papers), Biochemical effects in animals (4 papers), Stress Responses and Cortisol (4 papers), Bee Products Chemical Analysis (4 papers) and Sirtuins and Resveratrol in Medicine (4 papers). The work is most often cited by research in Biological Psychiatry (64 citations), Geriatrics and Gerontology (60 citations) and Behavioral Neuroscience (50 citations). Yi-Fang Li has collaborated with scholars based in China, Thailand and United States. Frequent co-authors include Rong‐Rong He, Hiroshi Kurihara, Yanping Wu, Bun Tsoi, Wen‐Jun Duan, Haibiao Gong, Zhuo Luo, Huaying Gao, Wen Li and Lu‐Ping Tang. Their work appears in journals such as Acta Pharmaceutica Sinica B, Scientific Reports, Food and Chemical Toxicology, Journal of Functional Foods and Journal of Ethnopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026